IGC Pharma, Inc. (IGC)

IGC Pharma Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	1.55	1.2	3.2	10.46	14.55	7.26
Short-Term Investments	-	-	0.15	-	0.08	5.08
Cash & Short-Term Investments	1.55	1.2	3.35	10.46	14.63	12.34
Cash Growth	-50.51%	-64.24%	-67.97%	-28.49%	18.55%	-51.82%
Accounts Receivable	0.04	0.04	0.11	0.13	0.18	0.13
Other Receivables	-	0.05	0.02	0.47	0.05	-
Receivables	0.04	0.09	0.13	0.6	0.22	0.13
Inventory	1.51	1.54	2.65	3.55	7.18	4.25
Prepaid Expenses	-	0.12	0.26	0.17	0.16	0.2
Other Current Assets	1.15	0.76	0.07	0.34	1.33	0.84
Total Current Assets	4.25	3.71	6.47	15.11	23.52	17.76
Property, Plant & Equipment	3.63	3.89	8.54	9.87	11.33	10.35
Long-Term Investments	-	-	-	-	0.01	0.01
Other Intangible Assets	1.8	1.62	1.17	0.92	0.41	0.25
Other Long-Term Assets	0.69	0.69	1	0.94	0.6	0.61
Total Assets	10.37	9.9	17.18	26.83	35.87	28.98
Accounts Payable	0.77	0.77	0.53	0.98	0.48	0.76
Accrued Expenses	2.03	1.02	0.88	1.21	1.18	0.86
Short-Term Debt	-	-	-	-	-	0.05
Current Portion of Long-Term Debt	-	-	-	0	0.3	-
Current Portion of Leases	-	0.12	0.13	0.12	0.09	0.09
Other Current Liabilities	-	0.42	0.36	0.12	0.32	0.18
Total Current Liabilities	2.8	2.34	1.9	2.44	2.37	1.95
Long-Term Debt	0.14	0.14	0.14	0.14	0.28	-
Long-Term Leases	0.04	0.08	0.21	0.34	0.41	0.49
Other Long-Term Liabilities	0.02	-	-	-	-	-
Total Liabilities	2.99	2.58	2.27	2.94	3.06	2.45
Common Stock	128.58	124.41	118.97	116.02	109.72	94.75
Retained Earnings	-117.76	-113.67	-100.67	-89.16	-74.14	-65.37
Comprehensive Income & Other	-3.44	-3.42	-3.39	-2.97	-2.77	-2.85
Total Common Equity	7.38	7.32	14.91	23.89	32.8	26.54
Shareholders' Equity	7.38	7.32	14.91	23.89	32.8	26.54
Total Liabilities & Equity	10.37	9.9	17.18	26.83	35.87	28.98
Total Debt	0.17	0.35	0.48	0.61	1.08	0.62
Net Cash (Debt)	1.38	0.85	2.87	9.85	13.55	11.72
Net Cash Growth	-49.15%	-70.27%	-70.87%	-27.33%	15.69%	-54.17%
Net Cash Per Share	0.02	0.01	0.05	0.20	0.32	0.30
Filing Date Shares Outstanding	77.45	75.64	53.08	51.74	48.33	41.19
Total Common Shares Outstanding	76.64	66.69	53.08	51.05	47.83	39.32
Working Capital	1.45	1.37	4.57	12.67	21.15	15.81
Book Value Per Share	0.10	0.11	0.28	0.47	0.69	0.67
Tangible Book Value	5.57	5.71	13.74	22.98	32.4	26.29
Tangible Book Value Per Share	0.07	0.09	0.26	0.45	0.68	0.67
Land	-	-	4.1	4.44	4.61	4.51
Buildings	-	2.3	2.3	2.81	3.82	2.54
Machinery	-	3.83	3.75	5.28	5.2	4.39
Construction In Progress	-	-	-	0.11	0.05	0.77

Source: S&P Capital IQ. Standard template. Financial Sources.